Home Tags Flatiron Health
Tag: Flatiron Health
Healthcare startups like Flatiron Health, One Medical, and Oscar Health all use an eerily similar font. We investigated why.
The companies made the font choices to stand out from traditional tech and healthcare companies, their design chiefs told Business Insider.
Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinica...
Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
Inside Flatiron Health’s swanky, new NYC headquarters, where the cold brew coffee flows and the conference rooms give off a serious living room ...
Business Insider popped in to the new location in July to get a feel for the space and observe some of the demonstrations from a recent Hackathon event. Here's a look at the company's new headquarters.
Roche on Tuesday bought the rest of Foundation Medicine, a company that collects genetic data from samples of cancer tissue or blood, for $2.4 billion. Roche had held a majority stake in the company, and the deal values Foundation at $5.3 billion.
Flatiron Health CEO Nat Turner explains why he and cofounder Zach Weinberg have been successful business partners since 2004.
Flatiron Health cofounder Zach Weinberg has three questions he uses as a guidepost for setting his priorities.
The CEO of a $2 billion startup says there’s a fundamental reason this company is the most successful one he’s built
Flatiron Health CEO Nat Turner said that when you have a mission you believe in, it attracts better talent, investment, and results.
The 32-year-old who sold his first company for $80 million and a second for $2 billion talks about writing to Richard Branson, how he’s a terrib...
Nat Turner, CEO of $2 billion startup Flatiron Health, says a cousin's battle with leukemia led him to his biggest success yet.
Startup cofounders who sold their first startup to Google for $70 million and their second for $1.9 billion reveal how they built wildly successful bu...
Nat Turner and Zach Weinberg sold their first company for more than $70 million to Google. Now, they've sold their second for $1.9 billion to a pharma giant.
The New York-based cancer technology startup had previously been valued at $1.2 billion after raising $175 million from investors including Roche.